Gynecological Cancers Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: G639243AFA92EN
Market Monitor Global

Abstracts

Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer.

This report contains market size and forecasts of Gynecological Cancers Therapeutics in Global, including the following market information:

Global Gynecological Cancers Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gynecological Cancers Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cervical Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gynecological Cancers Therapeutics include AstraZeneca, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc and Merck & Co., Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gynecological Cancers Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gynecological Cancers Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gynecological Cancers Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Cervical Cancer
• Ovarian Cancer
• Endometrial Cancer
• Vaginal Cancer
• Vulvar Cancer
• Other

Global Gynecological Cancers Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gynecological Cancers Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Targeted Therapy
• Chemotherapy

Global Gynecological Cancers Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gynecological Cancers Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gynecological Cancers Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gynecological Cancers Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• Merck & Co., Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gynecological Cancers Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gynecological Cancers Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GYNECOLOGICAL CANCERS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Gynecological Cancers Therapeutics Market Size: 2021 VS 2028
2.2 Global Gynecological Cancers Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gynecological Cancers Therapeutics Players in Global Market
3.2 Top Global Gynecological Cancers Therapeutics Companies Ranked by Revenue
3.3 Global Gynecological Cancers Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Gynecological Cancers Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gynecological Cancers Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gynecological Cancers Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Gynecological Cancers Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gynecological Cancers Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gynecological Cancers Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Cervical Cancer
  4.1.3 Ovarian Cancer
  4.1.4 Endometrial Cancer
  4.1.5 Vaginal Cancer
  4.1.6 Vulvar Cancer
  4.1.7 Other
4.2 By Type - Global Gynecological Cancers Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Gynecological Cancers Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Gynecological Cancers Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gynecological Cancers Therapeutics Market Size, 2021 & 2028
  5.1.2 Targeted Therapy
  5.1.3 Chemotherapy
5.2 By Application - Global Gynecological Cancers Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Gynecological Cancers Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Gynecological Cancers Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gynecological Cancers Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Gynecological Cancers Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Gynecological Cancers Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Gynecological Cancers Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gynecological Cancers Therapeutics Revenue, 2017-2028
  6.3.2 US Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.3.3 Canada Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Gynecological Cancers Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gynecological Cancers Therapeutics Revenue, 2017-2028
  6.4.2 Germany Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.4.3 France Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.4.5 Italy Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.4.6 Russia Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Gynecological Cancers Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gynecological Cancers Therapeutics Revenue, 2017-2028
  6.5.2 China Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.5.3 Japan Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.5.6 India Gynecological Cancers Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gynecological Cancers Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Gynecological Cancers Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gynecological Cancers Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.7.3 Israel Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Gynecological Cancers Therapeutics Market Size, 2017-2028
  6.7.5 UAE Gynecological Cancers Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Gynecological Cancers Therapeutics Major Product Offerings
  7.1.4 AstraZeneca Gynecological Cancers Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Bristol-Myers Squibb Company
  7.2.1 Bristol-Myers Squibb Company Corporate Summary
  7.2.2 Bristol-Myers Squibb Company Business Overview
  7.2.3 Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Major Product Offerings
  7.2.4 Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Company Key News
7.3 F. Hoffmann-La Roche Ltd
  7.3.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.3.2 F. Hoffmann-La Roche Ltd Business Overview
  7.3.3 F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 F. Hoffmann-La Roche Ltd Key News
7.4 GlaxoSmithKline plc
  7.4.1 GlaxoSmithKline plc Corporate Summary
  7.4.2 GlaxoSmithKline plc Business Overview
  7.4.3 GlaxoSmithKline plc Gynecological Cancers Therapeutics Major Product Offerings
  7.4.4 GlaxoSmithKline plc Gynecological Cancers Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 GlaxoSmithKline plc Key News
7.5 Merck & Co., Inc.
  7.5.1 Merck & Co., Inc. Corporate Summary
  7.5.2 Merck & Co., Inc. Business Overview
  7.5.3 Merck & Co., Inc. Gynecological Cancers Therapeutics Major Product Offerings
  7.5.4 Merck & Co., Inc. Gynecological Cancers Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Merck & Co., Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Gynecological Cancers Therapeutics Market Opportunities & Trends in Global Market
Table 2. Gynecological Cancers Therapeutics Market Drivers in Global Market
Table 3. Gynecological Cancers Therapeutics Market Restraints in Global Market
Table 4. Key Players of Gynecological Cancers Therapeutics in Global Market
Table 5. Top Gynecological Cancers Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gynecological Cancers Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gynecological Cancers Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gynecological Cancers Therapeutics Product Type
Table 9. List of Global Tier 1 Gynecological Cancers Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gynecological Cancers Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gynecological Cancers Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gynecological Cancers Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gynecological Cancers Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gynecological Cancers Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gynecological Cancers Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gynecological Cancers Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Gynecological Cancers Therapeutics Product Offerings
Table 32. AstraZeneca Gynecological Cancers Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Company Corporate Summary
Table 34. Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Product Offerings
Table 35. Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Ltd Corporate Summary
Table 37. F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Product Offerings
Table 38. F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline plc Corporate Summary
Table 40. GlaxoSmithKline plc Gynecological Cancers Therapeutics Product Offerings
Table 41. GlaxoSmithKline plc Gynecological Cancers Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Merck & Co., Inc. Corporate Summary
Table 43. Merck & Co., Inc. Gynecological Cancers Therapeutics Product Offerings
Table 44. Merck & Co., Inc. Gynecological Cancers Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Gynecological Cancers Therapeutics Segment by Type in 2021
Figure 2. Gynecological Cancers Therapeutics Segment by Application in 2021
Figure 3. Global Gynecological Cancers Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gynecological Cancers Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gynecological Cancers Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gynecological Cancers Therapeutics Revenue in 2021
Figure 8. By Type - Global Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gynecological Cancers Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gynecological Cancers Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Gynecological Cancers Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Company Gynecological Cancers Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Ltd Gynecological Cancers Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline plc Gynecological Cancers Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck & Co., Inc. Gynecological Cancers Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)